Related Experiment Video
Updated: Mar 8, 2026

09:33
In Vitro Assay to Measure Phosphatidylethanolamine Methyltransferase Activity
Published on: January 5, 2016
10.3K
Phosphatidylethanolamine is progressively exposed in RBCs during storage
M C Larson1, M S Karafin2,3, C A Hillery4
1Medical Imaging Department, University of Arizona, Tucson, Arizona, USA.
Transfusion Medicine (Oxford, England)
|January 31, 2017
Summary
Red blood cells (RBCs) exposed more phosphatidylethanolamine (PE) as they aged in storage, correlating with increased vesiculation and hemoglobin release. This finding sheds light on RBC clearance mechanisms post-transfusion.
Area of Science:
- Hematology
- Cell Biology
- Biochemistry
Background:
- Red blood cell (RBC) circulation decreases with storage age, but clearance mechanisms are unclear.
- Phosphatidylethanolamine (PE) is a phospholipid exposed on aged cells, acting as a phagocytosis ligand.
- Understanding RBC aging is crucial for transfusion efficacy.
Purpose of the Study:
- To quantify phosphatidylethanolamine (PE) exposure on donor RBCs during storage.
- To utilize the novel PE-specific probe, duramycin, for accurate measurement.
- To compare PE exposure with phosphatidylserine (PS) exposure over time.
Main Methods:
- AS-1 preserved RBC units were sampled weekly for six weeks.
- Duramycin was used to label and quantify PE exposure via flow cytometry.
- Phosphatidylserine (PS) exposure was assessed for comparative analysis.
Main Results:
- PE exposure on RBCs increased significantly with storage duration, reaching nearly 20% by 42 days.
- Increased PE exposure correlated with higher vesiculation and cell-free hemoglobin release.
- Phosphatidylserine (PS) exposure was considerably lower, at approximately 5% by 42 days.
Conclusions:
- Phosphatidylethanolamine (PE) exposure is a more prominent marker of RBC aging than phosphatidylserine (PS).
- Increased PE exposure during storage is linked to RBC vesiculation and hemoglobin release.
- These findings contribute to understanding RBC clearance and transfusion outcomes.

